Syngene is a leading integrated research, development, and manufacturing services organization offering scientific solutions to advance human and animal health, specialty chemicals, and consumer goods. The Company has client partnerships that range from a single specialist service to an end-to-end research, development and manufacturing program, accelerating the progress of a molecule to market through seamless integration. With a history spanning more than three decades, Syngene is a trusted partner, offering tailored solutions and scientific services for clients ranging from some of the world’s most sophisticated multinational corporations to small and medium-sized biotechs.
Syngene’s headquarters is situated on a 90-acre campus in Bangalore, India, serving as the hub for its discovery research and development activities. In addition to this campus, the Company operates three satellite campuses in Bangalore accommodating essential functions such as Human Resources, Legal, Finance, Clinical Development and Analytical Development.
Syngene’s operational footprint extends to two other locations: Mangalore and Hyderabad. These campuses play a significant role as a commercial-scale active pharmaceutical ingredient (API) manufacturing facility and a discovery research hub, respectively. Further details on our operations can be found in our Annual Report FY 2022-23, click here.
9 GRI 2-1
To be a world-class partner delivering innovative scientific solutions.
Integrity
Excellence
Professionalism
10 Our total number of permanent and non-permanent employees by gender have been reported in Annexure 3: GRI data sheet. We do not report employee data by region.
Our workforce10 of 8,500+ people include some 6,000 scientists supported by specialist and functional professionals to ensure smooth delivery of client projects. Together, their skills and experience enable us to deliver great science at all points in the value chain from early discovery to commercial manufacturing for both small and large molecules.
Syngene delivers innovative solutions and science-based services through four business divisions.11
The Discovery Services division assists clients in conducting early-stage research, identifying biological targets relevant to disease in patient populations and delivering drug candidates for further development. The Company has a specialized platform known as SynVent™ for integrated drug discovery. This platform provides clients with a complete project delivery capability based on differentiated technologies and our scientific expertise.
Dedicated R&D facilities with multi-disciplinary teams focused on biopharmaceutical research for clients including Bristol Myers Squibb (BMS), Amgen, and Baxter. Each research and development center includes exclusive research infrastructure and dedicated research teams to support client requirements.
The Development Services division focuses on small molecules and provides the client with services ranging from pre-clinical to clinical trials, including drug substance, drug product development and associated services in order to demonstrate the safety, tolerability, and efficacy of drugs. Syngene specializes in analytical services such as method development, validation, transfer, and reference standard qualification throughout the development process. It also works with performance chemicals and specialty materials using synthetic organic chemistry and polymer chemistry.
Manufacturing Services offers commercial-scale manufacturing of small molecules from a cGMP-compliant API manufacturing campus in Mangalore and development and manufacturing services for large molecules from the biologics manufacturing campus in Bangalore.
11 GRI 2-6
Syngene team at CPHI Barcelona - 2023, Gran Via Barcelona, Spain
Syngene collaborates with clients12 worldwide, with a significant proportion of them located in the United States. The Company provides customized, innovative solutions to a wide range of clients, including major multinational corporations as well as small and medium sized biotech and manufacturing companies.
12 GRI 2-6
*This is a representative selection of the customers Syngene works with. We work with over 450 customers across industry segments
*All product names, logos, brands, trademarks and registered trademarks are property of their respective owners
Further information on our value chain and business relationships13 can be found in our Annual Report FY 2022-23, click here.
13 GRI 2-6
CPHI Barcelona 2023
